Alignment Healthcare, Inc. (ALHC): a likely value trap?

Avoid — a whistleblower alleges the company manipulated the exact profit numbers this "cheap" valuation is based on.

⚠ TRAP Fundamentals64/100

Fell 31% in 9 trading day(s) — now $14.85

Why ALHC dropped

A former Alignment Healthcare executive filed a lawsuit alleging the company deliberately misclassified operating expenses as capital expenditures to inflate adjusted EBITDA and profitability metrics in 2024-2025; this news broke July 8, 2026 and has weighed on the stock since. Then on July 30, Q2 earnings added fuel: management said it would reinvest profit outperformance into 2027-2028 expansion, cutting near-term (second-half) profit share versus last year, and the stock fell another ~15-20% on heavy volume.

Fwd P/E 19.7Op margin 3.2%Rev growth 31.6%Debt/equity 124.7%Analyst upside 65.8%

How this scored 64/100

✅ Passes all 4 hard checks — profitable, cash-generative, and financially survivable.

✅ Makes money Net profit margin 0.9%

✅ Generates cash Free cash flow $189M

✅ Not drowning in debt Debt/equity 124.7% (limit 200%)

✅ Can pay its bills Current ratio 1.7 (needs 1+)

Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.

Profitability Does it actually make money? 8/25

Operating margin 3.2% 1/9

Net profit margin 0.9% 0/8

Return on equity 20.0% 6/8

Growth Is it getting bigger, or dying? 25/25

Revenue growth 31.6% 9/9

Earnings growth 142.9% 8/8

Expected profit change 296.1% 8/8

Value Is it cheap right now? 16/25

Forward P/E 19.7 6/10

PEG ratio unknown 2/8

Analyst target upside 65.8% 7/7

Balance sheet Will it survive? 15/25

Debt / equity 124.7% 4/10

Current ratio 1.7 4/8

Free cash flow $189M 7/7

🔒 Read the full AI analysis

Create a free account to unlock the bull case and the risks for ALHC — plus today's other picks.

Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-08-03. Research only — not financial advice.